IRVINE, CA, Feb 03, 2014 (Marketwired via COMTEX) -- Edwards Lifesciences Corporation EW +2.95% , the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended December 31, 2013, of $75.8 million, or $0.68 per diluted share, and non-GAAP net income of $101.5 million, or $0.91 per diluted share.
Help employers find you! Check out all the jobs and post your resume.
